BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS. 2005;19:2109-2116. [PMID: 16284460 DOI: 10.1097/01.aids.0000194808.20035.c1] [Cited by in Crossref: 209] [Cited by in F6Publishing: 204] [Article Influence: 13.9] [Reference Citation Analysis]
Number Citing Articles
1 Maniewski U, Payen MC, Delforge M, De Wit S. Is systematic screening and treatment for latent tuberculosis infection in HIV patients useful in a low endemic setting? Acta Clin Belg 2017;72:238-41. [PMID: 27686180 DOI: 10.1080/17843286.2016.1237696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Dravid A, Natarajan K, Medisetty M, Gawali R, Mahajan U, Kulkarni M, Saraf C, Ghanekar C, Kore S, Rathod N, Dravid M. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India. BMC Infect Dis 2019;19:714. [PMID: 31409289 DOI: 10.1186/s12879-019-4361-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
3 Bisson GP, Zetola N, Collman RG. Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge. Curr HIV/AIDS Rep 2015;12:107-16. [PMID: 25772785 DOI: 10.1007/s11904-015-0256-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
4 Edmonds A, Lusiama J, Napravnik S, Kitetele F, Van Rie A, Behets F. Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children. Int J Epidemiol 2009;38:1612-21. [PMID: 19448046 DOI: 10.1093/ije/dyp208] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
5 Wilkinson KA, Seldon R, Meintjes G, Rangaka MX, Hanekom WA, Maartens G, Wilkinson RJ. Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis. Am J Respir Crit Care Med 2009;180:674-83. [PMID: 19628776 DOI: 10.1164/rccm.200904-0568OC] [Cited by in Crossref: 49] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
6 Nelson AM, Manabe YC, Lucas SB. Immune Reconstitution Inflammatory Syndrome (IRIS): What pathologists should know. Semin Diagn Pathol 2017;34:340-51. [PMID: 28552210 DOI: 10.1053/j.semdp.2017.04.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
7 Kiragga AN, Castelnuovo B, Kamya MR, Moore R, Manabe YC. Regional differences in predictive accuracy of WHO immunologic failure criteria. AIDS 2012;26:768-70. [PMID: 22269974 DOI: 10.1097/QAD.0b013e32835143e3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
8 Abgrall S, del Giudice P, Melica G, Costagliola D. HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years. AIDS 2010;24:763-71. [DOI: 10.1097/qad.0b013e3283366747] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
9 Tenforde MW, Gupte N, Dowdy DW, Asmuth DM, Balagopal A, Pollard RB, Sugandhavesa P, Lama JR, Pillay S, Cardoso SW, Pawar J, Santos B, Riviere C, Mwelase N, Kanyama C, Kumwenda J, Hakim JG, Kumarasamy N, Bollinger R, Semba RD, Campbell TB, Gupta A; ACTG PEARLS and NWCS 319 Study Group. C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. PLoS One 2015;10:e0117424. [PMID: 25719208 DOI: 10.1371/journal.pone.0117424] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
10 Gupte AN, Kadam D, Sangle S, Rewari BB, Salvi S, Chavan A, Nimkar S, Golub J, Gupte N, Gupta A, Marbaniang I, Mave V. Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India. BMC Infect Dis 2019;19:914. [PMID: 31664933 DOI: 10.1186/s12879-019-4569-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Rangaka MX, Gideon HP, Wilkinson KA, Pai M, Mwansa-Kambafwile J, Maartens G, Glynn JR, Boulle A, Fielding K, Goliath R, Titus R, Mathee S, Wilkinson RJ. Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms. Eur Respir J 2012;39:163-71. [PMID: 21719487 DOI: 10.1183/09031936.00058911] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
12 Girardi E, Palmieri F, Angeletti C, Vanacore P, Matteelli A, Gori A, Carbonara S, Ippolito G. Impact of previous ART and of ART initiation on outcome of HIV-associated tuberculosis. Clin Dev Immunol 2012;2012:931325. [PMID: 22489253 DOI: 10.1155/2012/931325] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
13 Okonko IO, Ejike IU, Innocent-Adiele C, Cookey TI. HIV coinfections with tuberculosis among HIV-1 infected individuals in old cross river state, Nigeria. J Immunoassay Immunochem 2020;41:245-56. [PMID: 31957554 DOI: 10.1080/15321819.2020.1717527] [Reference Citation Analysis]
14 Komati S, Shaw PA, Stubbs N, Mathibedi MJ, Malan L, Sangweni P, Metcalf JA, Masur H, Hassim S. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa. AIDS 2010;24:1849-55. [PMID: 20622529 DOI: 10.1097/QAD.0b013e32833a2507] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
15 Evenblij K, Verbon A, van Leth F. Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in The Netherlands: a mixed-method design. BMC Public Health 2016;16:915. [PMID: 27585867 DOI: 10.1186/s12889-016-3539-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
16 Maheswaran H, Barton P. Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysis. PLoS One 2012;7:e30457. [PMID: 22291958 DOI: 10.1371/journal.pone.0030457] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
17 Nanoo A, Izu A, Ismail NA, Ihekweazu C, Abubakar I, Mametja D, Madhi SA. Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysis. Lancet Infect Dis 2015;15:1066-76. [PMID: 26112077 DOI: 10.1016/S1473-3099(15)00147-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
18 Cox HS, McDermid C, Azevedo V, Muller O, Coetzee D, Simpson J, Barnard M, Coetzee G, van Cutsem G, Goemaere E. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS One 2010;5:e13901. [PMID: 21085569 DOI: 10.1371/journal.pone.0013901] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
19 Assebe LF, Reda HL, Wubeneh AD, Lerebo WT, Lambert SM. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study. BMC Public Health 2015;15:346. [PMID: 25886730 DOI: 10.1186/s12889-015-1719-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
20 Qvist T, Johansen IS, Pressler T, Høiby N, Andersen AB, Katzenstein TL, Bjerrum S. Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria--experiences from the Danish Cystic Fibrosis cohort study. BMC Infect Dis 2014;14:655. [PMID: 25471640 DOI: 10.1186/s12879-014-0655-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
21 Lahuerta M, Ue F, Hoffman S, Elul B, Kulkarni SG, Wu Y, Nuwagaba-Biribonwoha H, Remien RH, El Sadr W, Nash D. The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved 2013;24:359-83. [PMID: 23377739 DOI: 10.1353/hpu.2013.0014] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 7.8] [Reference Citation Analysis]
22 Karo B, Krause G, Castell S, Kollan C, Hamouda O, Haas W; ClinSurv HIV Study Group. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy. BMC Infect Dis 2017;17:517. [PMID: 28743248 DOI: 10.1186/s12879-017-2627-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
23 Sovershaeva E, Kranzer K, Mchugh G, Bandason T, Majonga ED, Usmani OS, Rowland-Jones S, Gutteberg T, Flægstad T, Ferrand RA, Odland JØ. History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children. AIDS 2019;33:1711-8. [PMID: 31107249 DOI: 10.1097/QAD.0000000000002265] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Marais BJ, Rabie H, Cotton MF. TB and HIV in children - advances in prevention and management. Paediatr Respir Rev 2011;12:39-45. [PMID: 21172674 DOI: 10.1016/j.prrv.2010.09.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
25 Lawn SD, Wood R. Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis 2011;204 Suppl 4:S1159-67. [PMID: 21996698 DOI: 10.1093/infdis/jir411] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 6.8] [Reference Citation Analysis]
26 Bacaër N, Ouifki R, Pretorius C, Wood R, Williams B. Modeling the joint epidemics of TB and HIV in a South African township. J Math Biol 2008;57:557-93. [PMID: 18414866 DOI: 10.1007/s00285-008-0177-z] [Cited by in Crossref: 66] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
27 Eshun-Wilson I, Taljaard JJ, Nachega JB. Sub-optimal CD4 T-lymphocyte responses among HIV infected patients who develop TB during the first year of ART. J AIDS Clin Res 2012;3:1000135. [PMID: 22442755 DOI: 10.4172/2155-6113.1000135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
28 Mitku AA, Dessie ZG, Muluneh EK, Workie DL. Prevalence and associated factors of TB/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia. Afr Health Sci 2016;16:588-95. [PMID: 27605976 DOI: 10.4314/ahs.v16i2.29] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
29 Hanekom WA, Lawn SD, Dheda K, Whitelaw A. Tuberculosis research update. Trop Med Int Health 2010;15:981-9. [PMID: 20561306 DOI: 10.1111/j.1365-3156.2010.02568.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
30 Lawn SD, Wood R, Wilkinson RJ. Changing concepts of "latent tuberculosis infection" in patients living with HIV infection. Clin Dev Immunol 2011;2011:980594. [PMID: 20936108 DOI: 10.1155/2011/980594] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
31 Mulu A, Liebert UG, Maier M. Virological efficacy and immunological recovery among Ethiopian HIV-1 infected adults and children. BMC Infect Dis 2014;14:28. [PMID: 24422906 DOI: 10.1186/1471-2334-14-28] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
32 Corbett EL, Bandason T, Cheung YB, Munyati S, Godfrey-Faussett P, Hayes R, Churchyard G, Butterworth A, Mason P. Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med 2007;4:e22. [PMID: 17199408 DOI: 10.1371/journal.pmed.0040022] [Cited by in Crossref: 74] [Cited by in F6Publishing: 74] [Article Influence: 5.3] [Reference Citation Analysis]
33 French N, Kaleebu P, Pisani E, Whitworth JA. Human immunodeficiency virus (HIV) in developing countries. Ann Trop Med Parasitol 2006;100:433-54. [PMID: 16899147 DOI: 10.1179/136485906X97390] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
34 Du Bruyn E, Ruzive S, Lindestam Arlehamn CS, Sette A, Sher A, Barber DL, Wilkinson RJ, Riou C. Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis. Mucosal Immunol 2021;14:491-9. [PMID: 32678272 DOI: 10.1038/s41385-020-0322-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
35 Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, Kirui FK, Badal-Faesen S, Lagat D, Nyirenda M, Naidoo K, Hakim J, Mugyenyi P, Henostroza G, Leger PD, Lama JR, Mohapi L, Alave J, Mave V, Veloso VG, Pillay S, Kumarasamy N, Bao J, Hogg E, Jones L, Zolopa A, Kumwenda J, Gupta A; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial. Lancet 2016;387:1198-209. [PMID: 27025337 DOI: 10.1016/S0140-6736(16)00546-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 8.6] [Reference Citation Analysis]
36 Uy J, Yang R, Wirtz V, Sheppard L, Farajallah A, Mcgrath D. Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine. AIDS Care 2011;23:1500-4. [DOI: 10.1080/09540121.2011.565033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
37 Jerene D, Naess A, Lindtjørn B. Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients. AIDS Res Ther 2006;3:10. [PMID: 16600050 DOI: 10.1186/1742-6405-3-10] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
38 Lawn SD, Myer L, Bekker L, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 2006;20:1605-12. [DOI: 10.1097/01.aids.0000238406.93249.cd] [Cited by in Crossref: 238] [Cited by in F6Publishing: 227] [Article Influence: 15.9] [Reference Citation Analysis]
39 Alebel A, Demant D, Petrucka P, Sibbritt D. Effects of undernutrition on mortality and morbidity among adults living with HIV in sub-Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis 2021;21:1. [PMID: 33390160 DOI: 10.1186/s12879-020-05706-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Ayele HT, Mourik MS, Debray TP, Bonten MJ. Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials. PLoS One 2015;10:e0142290. [PMID: 26551023 DOI: 10.1371/journal.pone.0142290] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 8.3] [Reference Citation Analysis]
41 Walensky RP, Park JE, Wood R, Freedberg KA, Scott CA, Bekker LG, Losina E, Mayer KH, Seage GR 3rd, Paltiel AD. The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clin Infect Dis 2012;54:1504-13. [PMID: 22474224 DOI: 10.1093/cid/cis225] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 8.0] [Reference Citation Analysis]
42 Lawn SD, Kranzer K, Wood R. Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med 2009;30:685-99, viii. [PMID: 19925961 DOI: 10.1016/j.ccm.2009.08.010] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 6.9] [Reference Citation Analysis]
43 Lannoy LH, Cortez-Escalante JJ, Evangelista Mdo S, Romero GA. Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District. Rev Soc Bras Med Trop 2008;41:549-55. [PMID: 19142430 DOI: 10.1590/s0037-86822008000600001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
44 de Siqueira-Filha NT, Legood R, Cavalcanti A, Santos AC. Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV: A Systematic Literature Review. Value Health 2018;21:482-90. [PMID: 29680106 DOI: 10.1016/j.jval.2017.09.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
45 Uyei J, Coetzee D, Macinko J, Weinberg SL, Guttmacher S. Measuring the degree of integrated tuberculosis and HIV service delivery in Cape Town, South Africa. Health Policy Plan 2014;29:42-55. [PMID: 23274439 DOI: 10.1093/heapol/czs131] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
46 Batista Jd, de Albuquerque Mde F, Maruza M, Ximenes RA, Santos ML, Montarroyos UR, de Barros Miranda-Filho D, Lacerda HR, Rodrigues LC. Incidence and risk factors for tuberculosis in people living with HIV: cohort from HIV referral health centers in Recife, Brazil. PLoS One 2013;8:e63916. [PMID: 23675515 DOI: 10.1371/journal.pone.0063916] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
47 Zachariah R, Van Damme W, Arendt V, Schmit JC, Harries AD. The HIV/AIDS epidemic in sub-Saharan Africa: thinking ahead on programmatic tasks and related operational research. J Int AIDS Soc 2011;14 Suppl 1:S7. [PMID: 21967983 DOI: 10.1186/1758-2652-14-S1-S7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
48 Long B, Liang SY, Koyfman A, Gottlieb M. Tuberculosis: a focused review for the emergency medicine clinician. Am J Emerg Med 2020;38:1014-22. [PMID: 31902701 DOI: 10.1016/j.ajem.2019.12.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
49 Wester CW, Bussmann H, Koethe J, Moffat C, Vermund S, Essex M, Marlink RG. Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges. HIV Ther 2009;3:501-26. [PMID: 20161344 DOI: 10.2217/hiv.09.35] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
50 Bhattacharya D, Danaviah S, Muema DM, Akilimali NA, Moodley P, Ndung'u T, Das G. Cellular Architecture of Spinal Granulomas and the Immunological Response in Tuberculosis Patients Coinfected with HIV. Front Immunol 2017;8:1120. [PMID: 28955338 DOI: 10.3389/fimmu.2017.01120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
51 Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S. Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana. PLoS One 2018;13:e0192030. [PMID: 29385208 DOI: 10.1371/journal.pone.0192030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
52 Anandaiah A, Dheda K, Keane J, Koziel H, Moore DA, Patel NR. Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection. Am J Respir Crit Care Med 2011;183:987-97. [PMID: 21177884 DOI: 10.1164/rccm.201008-1246CI] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
53 Dieye TN, Ndiaye BP, Dieng AB, Fall M, Brittain N, Vermaak S, Camara M, Diop-Ndiaye H, Ngom-Gueye NF, Diaw PA, Toure-Kane C, Sow PS, Mboup S, McShane H. Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects. PLoS One 2013;8:e67177. [PMID: 23840618 DOI: 10.1371/journal.pone.0067177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
54 Chamie G, Wandera B, Marquez C, Kato-Maeda M, Kamya MR, Havlir DV, Charlebois ED. Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach. Trop Med Int Health 2015;20:537-45. [PMID: 25583212 DOI: 10.1111/tmi.12459] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
55 Lawn SD, Myer L, Bekker LG, Wood R. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis 2006;6:59. [PMID: 16551345 DOI: 10.1186/1471-2334-6-59] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 5.3] [Reference Citation Analysis]
56 Charalambous S, Grant AD, Innes C, Hoffmann CJ, Dowdeswell R, Pienaar J, Fielding KL, Churchyard GJ. Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme. AIDS 2010;24 Suppl 5:S5-13. [PMID: 21079429 DOI: 10.1097/01.aids.0000391010.02774.6f] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
57 Hermans SM, van Leth F, Manabe YC, Hoepelman AI, Lange JM, Kambugu A. Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study. HIV Med 2012;13:337-44. [PMID: 22296211 DOI: 10.1111/j.1468-1293.2011.00980.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
58 Akolo C, Bada F, Okpokoro E, Nwanne O, Iziduh S, Usoroh E, Ali T, Ibeziako V, Oladimeji O, Odo M. Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons. World J Virol 2015;4:105-12. [PMID: 25964875 DOI: 10.5501/wjv.v4.i2.105] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
59 Pollock KM, Montamat-Sicotte DJ, Cooke GS, Kapembwa MS, Kon OM, Grass L, Sampson RD, Taylor GP, Lalvani A. Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection. Immun Inflamm Dis 2015;3:141-53. [PMID: 26417433 DOI: 10.1002/iid3.50] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
60 Ballif M, Zürcher K, Reid SE, Boulle A, Fox MP, Prozesky HW, Chimbetete C, Zwahlen M, Egger M, Fenner L; International Epidemiology Database to Evaluate AIDS in Southern Africa (IeDEA-SA). Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes. BMJ Open 2018;8:e017405. [PMID: 29330173 DOI: 10.1136/bmjopen-2017-017405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
61 Abo Y, Minga A, Menan H, Danel C, Ouassa T, Dohoun L, Bomisso G, Tanoh A, Messou E, Eholié S, Lewden C, Anglaret X. Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008. BMC Infect Dis 2013;13:607. [PMID: 24373303 DOI: 10.1186/1471-2334-13-607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
62 Kendall MA, Lalloo U, Fletcher CV, Wu X, Podany AT, Cardoso SW, Ive P, Benson CA; ACTG A5290 Protocol Team. Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin vs. Lopinavir/Ritonavir + Daily Rifabutin for Treatment of HIV-TB Coinfection. Clin Infect Dis 2021:ciab097. [PMID: 33560349 DOI: 10.1093/cid/ciab097] [Reference Citation Analysis]
63 Akanbi MO, Achenbach CJ, Feinglass J, Taiwo B, Onu A, Pho MT, Agbaji O, Kanki P, Murphy RL. Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study. AIDS Res Hum Retroviruses 2013;29:931-7. [PMID: 23316724 DOI: 10.1089/AID.2012.0231] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
64 Kufa T, Mabuto T, Muchiri E, Charalambous S, Rosillon D, Churchyard G, Harris RC. Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysis. PLoS One 2014;9:e111209. [PMID: 25393281 DOI: 10.1371/journal.pone.0111209] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
65 McInerney PA, Ncama BP, Wantland D, Bhengu BR, McGibbon C, Davis SM, Corless IB, Nicholas PK. Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa. Nurs Health Sci 2008;10:266-72. [PMID: 19128302 DOI: 10.1111/j.1442-2018.2008.00410.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
66 Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, El-Bassel N, Dolan K, Moazen B, Wirtz AL, Verster A, Altice FL. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. Lancet 2016;388:1115-26. [PMID: 27427456 DOI: 10.1016/S0140-6736(16)30769-3] [Cited by in Crossref: 94] [Cited by in F6Publishing: 53] [Article Influence: 18.8] [Reference Citation Analysis]
67 Munthali L, Khan PY, Mwaungulu NJ, Chilongo F, Floyd S, Kayange M, Glynn JR, French N, Crampin AC. The effect of HIV and antiretroviral therapy on characteristics of pulmonary tuberculosis in northern Malawi: a cross-sectional study. BMC Infect Dis 2014;14:107. [PMID: 24568242 DOI: 10.1186/1471-2334-14-107] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
68 Schmaltz CA, Sant'Anna FM, Neves SC, Velasque Lde S, Lourenço MC, Morgado MG, Rolla VC, Lopes GS. Influence of HIV infection on mortality in a cohort of patients treated for tuberculosis in the context of wide access to HAART, in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2009;52:623-8. [PMID: 19730270 DOI: 10.1097/QAI.0b013e3181b31e56] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
69 Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Paediatric tuberculosis. Lancet Infect Dis 2008;8:498-510. [PMID: 18652996 DOI: 10.1016/S1473-3099(08)70182-8] [Cited by in Crossref: 297] [Cited by in F6Publishing: 144] [Article Influence: 22.8] [Reference Citation Analysis]
70 Ewing AC, Ellington SR, Wiener JB, Chasela CS, Tegha G, Nelson JAE, Jamieson DJ, van der Horst C, Kourtis AP; BAN Study Team. Predictors of Perinatal HIV Transmission Among Women Without Prior Antiretroviral Therapy in a Resource-Limited Setting: The Breastfeeding, Antiretrovirals and Nutrition Study. Pediatr Infect Dis J 2019;38:508-12. [PMID: 30985546 DOI: 10.1097/INF.0000000000002220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
71 Roy M, Muyindike W, Vijayan T, Kanyesigye M, Bwana M, Wenger M, Martin J, Geng E. Implementation and Operational Research: Use of Symptom Screening and Sputum Microscopy Testing for Active Tuberculosis Case Detection Among HIV-Infected Patients in Real-World Clinical Practice in Uganda. J Acquir Immune Defic Syndr 2016;72:e86-91. [PMID: 27159224 DOI: 10.1097/QAI.0000000000001067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
72 Bocchino M, Bellofiore B, Matarese A, Galati D, Sanduzzi A. IFN-gamma release assays in tuberculosis management in selected high-risk populations. Expert Rev Mol Diagn 2009;9:165-77. [PMID: 19298140 DOI: 10.1586/14737159.9.2.165] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
73 Middelkoop K, Bekker LG, Myer L, Whitelaw A, Grant A, Kaplan G, McIntyre J, Wood R. Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. Am J Respir Crit Care Med 2010;182:1080-5. [PMID: 20558626 DOI: 10.1164/rccm.201004-0598OC] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
74 Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS. 2007;21:1441-1448. [PMID: 17589190 DOI: 10.1097/qad.0b013e328216f441] [Cited by in Crossref: 189] [Cited by in F6Publishing: 117] [Article Influence: 13.5] [Reference Citation Analysis]
75 Kasprowicz VO, Churchyard G, Lawn SD, Squire SB, Lalvani A. Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas. J Infect Dis 2011;204 Suppl 4:S1168-78. [PMID: 21996699 DOI: 10.1093/infdis/jir449] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
76 Gunda DW, Maganga SC, Nkandala I, Kilonzo SB, Mpondo BC, Shao ER, Kalluvya SE. Prevalence and Risk Factors of Active TB among Adult HIV Patients Receiving ART in Northwestern Tanzania: A Retrospective Cohort Study. Can J Infect Dis Med Microbiol 2018;2018:1346104. [PMID: 30073038 DOI: 10.1155/2018/1346104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
77 Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS One. 2012;7:e34156. [PMID: 22479548 DOI: 10.1371/journal.pone.0034156] [Cited by in Crossref: 123] [Cited by in F6Publishing: 122] [Article Influence: 13.7] [Reference Citation Analysis]
78 Reitz C, Coovadia A, Ko S, Meyers T, Strehlau R, Sherman G, Kuhn L, Abrams EJ. Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis. J Infect Dis 2010;201:1121-31. [PMID: 20214476 DOI: 10.1086/651454] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
79 Lawn SD, Little F, Bekker LG, Kaplan R, Campbel E, Orrell C, Wood R. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS 2009;23:335-42. [PMID: 19114870 DOI: 10.1097/QAD.0b013e328321823f] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 7.3] [Reference Citation Analysis]
80 Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenol B, Saghayam S, Yepthomi T, Balakrishnan P, Flanigan T, Solomon S, Mayer KH. Gender-based differences in treatment and outcome among HIV patients in South India. J Womens Health (Larchmt) 2008;17:1471-5. [PMID: 18954236 DOI: 10.1089/jwh.2007.0670] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
81 van Halsema CL, Okhai H, Hill T, Sabin CA; UK Collaborative HIV Cohort (UK CHIC) Study. Incidence of and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the United Kingdom. AIDS 2020;34:1813-21. [PMID: 32501837 DOI: 10.1097/QAD.0000000000002599] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, Domínguez J, Duarte R, Ernst M, Eyuboglu FO, Gerogianni I, Girardi E, Goletti D, Janssens J, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C. Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study. Am J Respir Crit Care Med 2014;190:1168-76. [DOI: 10.1164/rccm.201405-0967oc] [Cited by in Crossref: 138] [Cited by in F6Publishing: 57] [Article Influence: 19.7] [Reference Citation Analysis]
83 Boah M, Jin B, Adampah T, Wang W, Wang K. The scale-up of antiretroviral therapy coverage was strongly associated with the declining tuberculosis morbidity in Africa during 2000-2018. Public Health 2021;191:48-54. [PMID: 33508661 DOI: 10.1016/j.puhe.2020.04.021] [Reference Citation Analysis]
84 Ngongondo M, Miyahara S, Hughes MD, Sun X, Bisson GP, Gupta A, Kumwenda J, Lavenberg JA, Torres TS, Nyirenda M, Kidonge KK, Hosseinipour MC; AIDS Clinical Trials Group A5274 (REMEMBER) Study Team. Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial. J Acquir Immune Defic Syndr 2018;78:54-61. [PMID: 29406428 DOI: 10.1097/QAI.0000000000001641] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
85 Scaravilli F, Bazille C, Gray F. Neuropathologic contributions to understanding AIDS and the central nervous system. Brain Pathol 2007;17:197-208. [PMID: 17388950 DOI: 10.1111/j.1750-3639.2007.00047.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
86 Lazarous DG, O'Donnell AE. Pulmonary infections in the HIV-infected patient in the era of highly active antiretroviral therapy: an update. Curr Infect Dis Rep 2007;9:228-32. [PMID: 17430705 DOI: 10.1007/s11908-007-0036-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
87 Skolimowska KH, Rangaka MX, Meintjes G, Pepper DJ, Seldon R, Matthews K, Wilkinson RJ, Wilkinson KA. Altered ratio of IFN-γ/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome. PLoS One 2012;7:e46481. [PMID: 23071578 DOI: 10.1371/journal.pone.0046481] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
88 Dheda K, Barry CE 3rd, Maartens G. Tuberculosis. Lancet 2016;387:1211-26. [PMID: 26377143 DOI: 10.1016/S0140-6736(15)00151-8] [Cited by in Crossref: 288] [Cited by in F6Publishing: 116] [Article Influence: 48.0] [Reference Citation Analysis]
89 Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa. PLoS One 2010;5:e10527. [PMID: 20479873 DOI: 10.1371/journal.pone.0010527] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
90 Iroezindu MO, Ofondu EO, Mbata GC, van Wyk B, Hausler HP, Dh A, Lynen L, Hopewell PC. Factors Associated with Prevalent Tuberculosis Among Patients Receiving Highly Active Antiretroviral Therapy in a Nigerian Tertiary Hospital. Ann Med Health Sci Res 2016;6:120-8. [PMID: 27213096 DOI: 10.4103/2141-9248.181837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
91 Srirangaraj S, Venkatesha D. Opportunistic infections in relation to antiretroviral status among AIDS patients from south India. Indian J Med Microbiol 2011;29:395-400. [PMID: 22120801 DOI: 10.4103/0255-0857.90175] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
92 Norrby M, Wannheden C, Ekström AM, Berggren I, Lindquist L. Incidence of tuberculosis and the need of prophylactic treatment in persons living with HIV in Stockholm during the era of anti-retroviral therapy 1996-2013. Infect Dis (Lond) 2018;50:807-16. [PMID: 30362392 DOI: 10.1080/23744235.2018.1486511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Smith CM, Lessells R, Grant AD, Herbst K, Tanser F. Spatial clustering of drug-resistant tuberculosis in Hlabisa subdistrict, KwaZulu-Natal, 2011-2015. Int J Tuberc Lung Dis 2018;22:287-93. [PMID: 29471906 DOI: 10.5588/ijtld.17.0457] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
94 Golub JE, Astemborski J, Ahmed M, Cronin W, Mehta SH, Kirk GD, Vlahov D, Chaisson RE. Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users. J Acquir Immune Defic Syndr 2008;49:532-7. [PMID: 18989223 DOI: 10.1097/QAI.0b013e31818d5c1c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
95 Walensky RP, Borre ED, Bekker LG, Hyle EP, Gonsalves GS, Wood R, Eholié SP, Weinstein MC, Anglaret X, Freedberg KA, Paltiel AD. Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid. Ann Intern Med 2017;167:618-29. [PMID: 28847013 DOI: 10.7326/M17-1358] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
96 Corbett EL, Muzangwa J, Chaka K, Dauya E, Cheung YB, Munyati SS, Reid A, Hakim J, Chandiwana S, Mason PR, Butterworth AE, Houston S. Nursing and Community Rates of Mycobacterium tuberculosis Infection among Students in Harare, Zimbabwe. Clinical Infectious Diseases 2007;44:317-23. [DOI: 10.1086/509926] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
97 Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;CD000171. [PMID: 20091503 DOI: 10.1002/14651858.cd000171.pub3] [Cited by in Crossref: 119] [Cited by in F6Publishing: 173] [Article Influence: 10.8] [Reference Citation Analysis]
98 Mendonça M, Tanji MM, Silva LC, Silveira GG, Oliveira SC, Duarte AJ, Benard G. Deficient in vitro anti-mycobacterial immunity despite successful long-term highly active antiretroviral therapy in HIV-infected patients with past history of tuberculosis infection or disease. Clin Immunol 2007;125:60-6. [PMID: 17631053 DOI: 10.1016/j.clim.2007.06.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
99 Lin WC, Lin HH, Lee SS, Sy CL, Wu KS, Chen JK, Tsai HC, Chen YS. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country. J Microbiol Immunol Infect 2016;49:729-36. [PMID: 25442858 DOI: 10.1016/j.jmii.2014.08.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
100 Park WB, Choe PG, Jo JH, Kim SH, Bang JH, Kim HB, Kim NJ, Oh MD, Choe KW. Tuberculosis manifested by immune reconstitution inflammatory syndrome during HAART. AIDS 2007;21:875-7. [PMID: 17415046 DOI: 10.1097/QAD.0b013e3280f7751f] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
101 Gupta A, Nayak U, Ram M, Bhosale R, Patil S, Basavraj A, Kakrani A, Philip S, Desai D, Sastry J, Bollinger RC; Byramjee Jeejeebhoy Medical College-Johns Hopkins University Study Group. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clin Infect Dis 2007;45:241-9. [PMID: 17578786 DOI: 10.1086/518974] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
102 Hwang JH, Choe PG, Kim NH, Bang JH, Song KH, Park WB, Kim ES, Park SW, Kim HB, Kim NJ, Oh MD, Choe KW. Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infection. J Korean Med Sci 2013;28:374-7. [PMID: 23486534 DOI: 10.3346/jkms.2013.28.3.374] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
103 Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KA; CEPAC-International Investigators. Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. J Infect Dis 2008;197:1324-32. [PMID: 18422445 DOI: 10.1086/587184] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
104 Walensky RP, Borre ED, Bekker LG, Resch SC, Hyle EP, Wood R, Weinstein MC, Ciaranello AL, Freedberg KA, Paltiel AD. The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa. Ann Intern Med 2016;165:325-33. [PMID: 27240120 DOI: 10.7326/M16-0799] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
105 Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, Elliott JH, Murdoch D, Wilkinson RJ, Seyler C, John L, van der Loeff MS, Reiss P, Lynen L, Janoff EN, Gilks C, Colebunders R, International Network for the Study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: Case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8:516-523. [PMID: 18652998 DOI: 10.1016/s1473-3099(08)70184-1] [Cited by in Crossref: 453] [Cited by in F6Publishing: 220] [Article Influence: 34.8] [Reference Citation Analysis]
106 Temesgen B, Kibret GD, Alamirew NM, Melkamu MW, Hibstie YT, Petrucka P, Alebel A. Incidence and predictors of tuberculosis among HIV-positive adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: a retrospective record review. BMC Public Health 2019;19:1566. [PMID: 31771552 DOI: 10.1186/s12889-019-7912-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
107 Zhou J, Elliott J, Li PC, Lim PL, Kiertiburanakul S, Kumarasamy N, Merati TP, Pujari S, Chen YM, Phanuphak P, Vonthanak S, Sirisanthana T, Sungkanuparph S, Lee CK, Kamarulzaman A, Oka S, Zhang F, Tau G, Ditangco R. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. BMC Infect Dis 2009;9:46. [PMID: 19383122 DOI: 10.1186/1471-2334-9-46] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
108 Tiruneh F, Deyas Y. Effect of highly active antiretroviral treatment on TB incidence among HIV infected children and their clinical profile, retrospective cohort study, South West Ethiopia. Sci Rep 2020;10:21468. [PMID: 33293656 DOI: 10.1038/s41598-020-78466-0] [Reference Citation Analysis]
109 Awadalla H, El-Samani F, Soghaier MA, Makki M. Risk Factors Associated with the Development of Tuberculosis Among HIV-Infected Patients in Khartoum in 2010. AIMS Public Health 2015;2:784-92. [PMID: 29546135 DOI: 10.3934/publichealth.2015.4.784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Varghese GM, Janardhanan J, Ralph R, Abraham OC. The Twin Epidemics of Tuberculosis and HIV. Curr Infect Dis Rep 2013;15:77-84. [DOI: 10.1007/s11908-012-0311-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
111 Dang LVP, Nguyen QH, Ishizaki A, Larsson M, Vu NTP, Do Duy C, Olson L, Dinh TT. Prevalence of Opportunistic Infections and Associated Factors in HIV-Infected Men Who Have Sex With Men on Antiretroviral Therapy in Bach Mai Hospital, Hanoi, Vietnam: A Case-Control Study. Am J Mens Health 2020;14:1557988320926743. [PMID: 32552402 DOI: 10.1177/1557988320926743] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Kruk A, Bannister W, Podlekareva DN, Chentsova NP, Rakhmanova AG, Horban A, Domingo P, Mocroft A, Lundgren JD, Kirk O; EuroSIDA study group. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors. AIDS 2011;25:1505-13. [PMID: 21610489 DOI: 10.1097/QAD.0b013e328348fafd] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
113 Kassa A, Teka A, Shewaamare A, Jerene D. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia. Trans R Soc Trop Med Hyg 2012;106:363-70. [PMID: 22521216 DOI: 10.1016/j.trstmh.2012.03.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
114 Laparra A, Lerolle N, Gerin M, Cheret A, De Castro N, Gallien S, Pourcher V, Lanternier F, Bourgarit A, Goujard C. Tumor necrosis factor-alpha inhibitors for extended or severe neurological immune reconstitution inflammatory syndrome in HIV-infected patients. AIDS 2021;35:995-7. [PMID: 33821825 DOI: 10.1097/QAD.0000000000002823] [Reference Citation Analysis]
115 Lawn SD, Churchyard G. Epidemiology of HIV-associated tuberculosis. Curr Opin HIV AIDS 2009;4:325-33. [PMID: 19532072 DOI: 10.1097/COH.0b013e32832c7d61] [Cited by in Crossref: 101] [Cited by in F6Publishing: 57] [Article Influence: 8.4] [Reference Citation Analysis]
116 Eldholm V, Rieux A, Monteserin J, Lopez JM, Palmero D, Lopez B, Ritacco V, Didelot X, Balloux F. Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis. Elife 2016;5:e16644. [PMID: 27502557 DOI: 10.7554/eLife.16644] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
117 Ahmed A, Mekonnen D, Shiferaw AM, Belayneh F, Yenit MK. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study. BMJ Open 2018;8:e016961. [PMID: 29437750 DOI: 10.1136/bmjopen-2017-016961] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
118 Lawn SD, Harries AD, Wood R. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS 2010;5:18-26. [PMID: 20046144 DOI: 10.1097/COH.0b013e328333850f] [Cited by in Crossref: 74] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
119 Maartens G, Wilkinson RJ. Tuberculosis. The Lancet 2007;370:2030-43. [DOI: 10.1016/s0140-6736(07)61262-8] [Cited by in Crossref: 213] [Cited by in F6Publishing: 90] [Article Influence: 15.2] [Reference Citation Analysis]
120 Mathema B, Andrews JR, Cohen T, Borgdorff MW, Behr M, Glynn JR, Rustomjee R, Silk BJ, Wood R. Drivers of Tuberculosis Transmission. J Infect Dis 2017;216:S644-53. [PMID: 29112745 DOI: 10.1093/infdis/jix354] [Cited by in Crossref: 58] [Cited by in F6Publishing: 40] [Article Influence: 14.5] [Reference Citation Analysis]
121 Auld AF, Mbofana F, Shiraishi RW, Alfredo C, Sanchez M, Ellerbrock TV, Nelson LJ. Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008. PLoS One 2013;8:e54665. [PMID: 23349948 DOI: 10.1371/journal.pone.0054665] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
122 Kibret KT, Yalew AW, Belaineh BG, Asres MM. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control study. PLoS One 2013;8:e64488. [PMID: 23762214 DOI: 10.1371/journal.pone.0064488] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
123 Miranda AE, Golub JE, Lucena Fde F, Maciel EN, Gurgel Mde F, Dietze R. Tuberculosis and AIDS co-morbidity in Brazil: linkage of the tuberculosis and AIDS databases. Braz J Infect Dis 2009;13:137-41. [PMID: 20140359 DOI: 10.1590/s1413-86702009000200013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
124 Frasca K, Cohn J. Integration of HIV and tuberculosis in the community. J Int Assoc Provid AIDS Care 2014;13:534-8. [PMID: 23776105 DOI: 10.1177/2325957413488183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
125 Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, Oremek G, Rakus Z, Gottschalk R, Stark S, Brodt H, Staszewski S. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 2008;22:2471-9. [DOI: 10.1097/qad.0b013e3283188415] [Cited by in Crossref: 70] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
126 Pettit AC, Mendes A, Jenkins C, Napravnik S, Freeman A, Shepherd BE, Dowdy D, Gill J, Rachlis A, Moore R, Sterling TR; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) investigators of International epidemiologic Databases to Evaluate AIDS (IeDEA). Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment. J Acquir Immune Defic Syndr 2016;72:572-8. [PMID: 27049511 DOI: 10.1097/QAI.0000000000001018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
127 Tadokera R, Meintjes G, Skolimowska KH, Wilkinson KA, Matthews K, Seldon R, Chegou NN, Maartens G, Rangaka MX, Rebe K, Walzl G, Wilkinson RJ. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J 2011;37:1248-59. [PMID: 20817712 DOI: 10.1183/09031936.00091010] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 9.2] [Reference Citation Analysis]
128 Baghaei P, Esmaeili S, Farshidpour M, Javanmard P, Marjani M, Moniri A, Nemati K, Tabarsi P. Diagnosing active and latent tuberculosis among Iranian HIV-infected patients. Clin Respir J 2018;12:62-7. [PMID: 27059900 DOI: 10.1111/crj.12479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
129 Zumla A, Chakaya J, Centis R, D'ambrosio L, Mwaba P, Bates M, Kapata N, Nyirenda T, Chanda D, Mfinanga S, Hoelscher M, Maeurer M, Migliori GB. Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies. The Lancet Respiratory Medicine 2015;3:220-34. [DOI: 10.1016/s2213-2600(15)00063-6] [Cited by in Crossref: 130] [Cited by in F6Publishing: 52] [Article Influence: 21.7] [Reference Citation Analysis]
130 Tiruneh F, Deyas Y. How Far Does Highly Active Antiretroviral Treatment Reduce TB Incidence among Children? A Marginal Structural Modeling Analysis, Southwest Ethiopia. Ethiop J Health Sci 2020;30:653-60. [PMID: 33911825 DOI: 10.4314/ejhs.v30i5.3] [Reference Citation Analysis]
131 Tiruneh G, Getahun A, Adeba E. Assessing the Impact of Isoniazid Preventive Therapy (IPT) on Tuberculosis Incidence and Predictors of Tuberculosis among Adult Patients Enrolled on ART in Nekemte Town, Western Ethiopia: A Retrospective Cohort Study. Interdiscip Perspect Infect Dis 2019;2019:1413427. [PMID: 31186628 DOI: 10.1155/2019/1413427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
132 Hsu DC, Kerr SJ, Thongpaeng P, Iampornsin T, Pett SL, Zaunders JJ, Avihingsanon A, Ubolyam S, Ananworanich J, Kelleher AD, Cooper DA. Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy. J Infect 2014;68:344-54. [PMID: 24325926 DOI: 10.1016/j.jinf.2013.11.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
133 Straetemans M, Bierrenbach AL, Nagelkerke N, Glaziou P, van der Werf MJ. The effect of tuberculosis on mortality in HIV positive people: a meta-analysis. PLoS One 2010;5:e15241. [PMID: 21209936 DOI: 10.1371/journal.pone.0015241] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
134 Manabe YC, Breen R, Perti T, Girardi E, Sterling TR. Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy. J Infect Dis 2009;199:437-44. [PMID: 19090776 DOI: 10.1086/595985] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
135 Igari H, Takayanagi S, Yahaba M, Tsuyuzaki M, Taniguchi T, Suzuki K. Prevalence of positive IGRAs and innate immune system in HIV-infected individuals in Japan. J Infect Chemother 2021;27:592-7. [PMID: 33386257 DOI: 10.1016/j.jiac.2020.11.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Lee SS, Lin HH, Tsai HC, Su IJ, Yang CH, Sun HY, Hung CC, Sy CL, Wu KS, Chen JK, Chen YS, Fang CT. A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study. PLoS One 2015;10:e0135801. [PMID: 26280669 DOI: 10.1371/journal.pone.0135801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
137 Uyei J, Coetzee D, Macinko J, Guttmacher S. Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review. The Lancet Infectious Diseases 2011;11:855-67. [DOI: 10.1016/s1473-3099(11)70145-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
138 Levison JH, Wood R, Scott CA, Ciaranello AL, Martinson NA, Rusu C, Losina E, Freedberg KA, Walensky RP. The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa. Clin Infect Dis 2013;56:587-97. [PMID: 23087386 DOI: 10.1093/cid/cis887] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
139 Lorenzana SB, Hughes MD, Grinsztejn B, Collier AC, Luz PM, Freedberg KA, Wood R, Levison JH, Mugyenyi PN, Salata R, Wallis CL, Weinstein MC, Schooley RT, Walensky RP. Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial. AIDS 2012;26:1083-93. [PMID: 22343964 DOI: 10.1097/QAD.0b013e32835221eb] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
140 Ouattara E, Messou E, Gabillard D, Seyler C, Anglaret X. Are a past history of tuberculosis and WHO clinical stage associated with incident tuberculosis in adults receiving antiretroviral therapy?, reply to Lawn et al. AIDS 2007;21:389-90. [PMID: 17255756 DOI: 10.1097/QAD.0b013e328011f964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
141 Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, Harrington M, Maher D, Williams BG, De Cock KM. The HIV-associated tuberculosis epidemic--when will we act? Lancet 2010;375:1906-19. [PMID: 20488516 DOI: 10.1016/S0140-6736(10)60409-6] [Cited by in Crossref: 150] [Cited by in F6Publishing: 91] [Article Influence: 13.6] [Reference Citation Analysis]
142 Cohen JM, Whittaker E, Walters S, Lyall H, Tudor-Williams G, Kampmann B. Presentation, diagnosis and management of tuberculosis in HIV-infected children in the UK. HIV Med 2008;9:277-84. [PMID: 18331563 DOI: 10.1111/j.1468-1293.2008.00559.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
143 Karo B, Haas W, Kollan C, Gunsenheimer-Bartmeyer B, Hamouda O, Fiebig L; German ClinSurv HIV Study Group. Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors. BMC Infect Dis 2014;14:148. [PMID: 24646042 DOI: 10.1186/1471-2334-14-148] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
144 Sanne IM, Westreich D, Macphail AP, Rubel D, Majuba P, Van Rie A. Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study. J Int AIDS Soc 2009;12:38. [PMID: 20017918 DOI: 10.1186/1758-2652-12-38] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
145 Naidoo K, Karim QA, Bhushan A, Naidoo K, Yende-Zuma N, McHunu PK, Frohlich J, Karim F, Upfold M, Kocheleff P, Abdool Karim SS. High rates of tuberculosis in patients accessing HAART in rural South Africa. J Acquir Immune Defic Syndr 2014;65:438-46. [PMID: 24256629 DOI: 10.1097/QAI.0000000000000060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
146 Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, Rutherford G, Mermin J. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 2007;21:713-9. [PMID: 17413692 DOI: 10.1097/QAD.0b013e328013f632] [Cited by in Crossref: 127] [Cited by in F6Publishing: 93] [Article Influence: 9.1] [Reference Citation Analysis]
147 Iroezindu MO. Disparities in the Magnitude of Human Immunodeficiency Virus-related Opportunistic Infections Between High and Low/Middle-income Countries: Is Highly Active Antiretroviral Therapy Changing the Trend? Ann Med Health Sci Res 2016;6:4-18. [PMID: 27144071 DOI: 10.4103/2141-9248.180234] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
148 Benova L, Fielding K, Greig J, Nyang'wa BT, Casas EC, da Fonseca MS, du Cros P. Association of BMI category change with TB treatment mortality in HIV-positive smear-negative and extrapulmonary TB patients in Myanmar and Zimbabwe. PLoS One 2012;7:e35948. [PMID: 22545150 DOI: 10.1371/journal.pone.0035948] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
149 Meintjes G, Rabie H, Wilkinson RJ, Cotton MF. Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy. Clin Chest Med 2009;30:797-810, x. [PMID: 19925968 DOI: 10.1016/j.ccm.2009.08.013] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
150 Lawn SD, Wilkinson RJ, Lipman MC, Wood R. Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med 2008;177:680-5. [PMID: 18202347 DOI: 10.1164/rccm.200709-1311PP] [Cited by in Crossref: 136] [Cited by in F6Publishing: 77] [Article Influence: 10.5] [Reference Citation Analysis]
151 Muga R, Ferreros I, Langohr K, de Olalla PG, Del Romero J, Quintana M, Alastrue I, Belda J, Tor J, Pérez-Hoyos S, Del Amo J; Spanish Multicenter Study Group of Seroconverters (GEMES). Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART. AIDS 2007;21:2521-7. [PMID: 18025889 DOI: 10.1097/QAD.0b013e3282f1c933] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
152 Lawn SD, Wood R, De Cock KM, Kranzer K, Lewis JJ, Churchyard GJ. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. The Lancet Infectious Diseases 2010;10:489-98. [DOI: 10.1016/s1473-3099(10)70078-5] [Cited by in Crossref: 125] [Cited by in F6Publishing: 80] [Article Influence: 11.4] [Reference Citation Analysis]
153 Martinson NA, Hoffmann CJ, Chaisson RE. Epidemiology of tuberculosis and HIV: recent advances in understanding and responses. Proc Am Thorac Soc 2011;8:288-93. [PMID: 21653530 DOI: 10.1513/pats.201010-064WR] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
154 Skogmar S, Schön T, Balcha TT, Sturegård E, Jansson M, Björkman P. Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count. PLoS One 2015;10:e0144292. [PMID: 26630153 DOI: 10.1371/journal.pone.0144292] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
155 Melkamu H, Seyoum B, Dessie Y. Determinants of Tuberculosis Infection among Adult HIV Positives Attending Clinical Care in Western Ethiopia: A Case-Control Study. AIDS Res Treat 2013;2013:279876. [PMID: 24222846 DOI: 10.1155/2013/279876] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
156 Tenforde MW, Yadav A, Dowdy DW, Gupte N, Shivakoti R, Yang WT, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Berendes S, Lama JR, Cardoso SW, Sugandhavesa P, Christian P, Semba RD, Campbell TB, Gupta A; NWCS319 and ACTG 5175 study team. Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study. J Acquir Immune Defic Syndr 2017;75:e71-9. [PMID: 28169875 DOI: 10.1097/QAI.0000000000001308] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
157 Lawn SD, Lipman MC, Easterbrook PJ. Immune reconstitution disease associated with mycobacterial infections. Curr Opin HIV AIDS 2008;3:425-31. [PMID: 19373001 DOI: 10.1097/COH.0b013e3282fe99dc] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
158 Eholié SP, Aoussi FE, Ouattara IS, Bissagnéné E, Anglaret X. HIV treatment and care in resource-constrained environments: challenges for the next decade. J Int AIDS Soc 2012;15:17334. [PMID: 22944479 DOI: 10.7448/IAS.15.2.17334] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
159 Meintjes G, Wilkinson KA, Rangaka MX, Skolimowska K, van Veen K, Abrahams M, Seldon R, Pepper DJ, Rebe K, Mouton P, van Cutsem G, Nicol MP, Maartens G, Wilkinson RJ. Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med 2008;178:1083-9. [PMID: 18755923 DOI: 10.1164/rccm.200806-858OC] [Cited by in Crossref: 107] [Cited by in F6Publishing: 70] [Article Influence: 8.2] [Reference Citation Analysis]
160 Golub JE, Durovni B, King BS, Cavalacante SC, Pacheco AG, Moulton LH, Moore RD, Chaisson RE, Saraceni V. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2008;22:2527-33. [PMID: 19005276 DOI: 10.1097/QAD.0b013e328311ac4e] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
161 Mzembe T, Mclean E, Khan PY, Koole O, Sichali L, Mwinuka V, Kayange M, Mzumara P, Dimba A, Crampin AC, Glynn JR. Risk of Mycobacterium tuberculosis transmission in an antiretroviral therapy clinic. AIDS 2018;32:2417-21. [PMID: 30234604 DOI: 10.1097/QAD.0000000000002006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
162 Taarnhøj GA, Engsig FN, Ravn P, Johansen IS, Larsen CS, Røge B, Andersen AB, Obel N. Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007. BMC Pulm Med 2011;11:26. [PMID: 21605366 DOI: 10.1186/1471-2466-11-26] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
163 Riou C, Berkowitz N, Goliath R, Burgers WA, Wilkinson RJ. Analysis of the Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells to Discriminate Latent from Active Tuberculosis in HIV-Uninfected and HIV-Infected Individuals. Front Immunol 2017;8:968. [PMID: 28848561 DOI: 10.3389/fimmu.2017.00968] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 10.5] [Reference Citation Analysis]
164 Bracchi M, van Halsema C, Post F, Awosusi F, Barbour A, Bradley S, Coyne K, Dixon-Williams E, Freedman A, Jelliman P, Khoo S, Leen C, Lipman M, Lucas S, Miller R, Seden K, Pozniak A. British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2019. HIV Med 2019;20 Suppl 6:s2-s83. [PMID: 31152481 DOI: 10.1111/hiv.12748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
165 Nahid P, Daley CL. Prevention of tuberculosis in HIV-infected patients. Curr Opin Infect Dis 2006;19:189-93. [PMID: 16514345 DOI: 10.1097/01.qco.0000216631.36316.62] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
166 Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011;24:351-376. [PMID: 21482729 DOI: 10.1128/cmr.00042-10] [Cited by in Crossref: 339] [Cited by in F6Publishing: 206] [Article Influence: 33.9] [Reference Citation Analysis]
167 Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr 2011;56:349-55. [PMID: 20926954 DOI: 10.1097/QAI.0b013e3181f9fb39] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
168 Eum SY, Lee YJ, Kwak HK, Min JH, Hwang SH, Via LE, Barry CE 3rd, Cho SN. Evaluation of the diagnostic utility of a whole-blood interferon-gamma assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille Calmette-Guerin (BCG)-vaccinated individuals. Diagn Microbiol Infect Dis 2008;61:181-6. [PMID: 18296002 DOI: 10.1016/j.diagmicrobio.2008.01.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
169 Grant AD, Bansi L, Ainsworth J, Anderson J, Delpech V, Easterbrook P, Fisher M, Gazzard B, Gilson R, Gompels M, Hill T, Johnson M, Leen C, Orkin C, Phillips AN, Porter K, Post F, Walsh J, Sabin CA; United Kingdom Collaborative HIV Cohort Study Group. Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? AIDS 2009;23:2507-15. [PMID: 19770622 DOI: 10.1097/QAD.0b013e3283320dfd] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
170 Etard JF, Diouf A, De Beaudrap P, Akoi K, Ngom-Guèye NF, Ndiaye I, Ecochard R, Sow PS, Eric D. Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal. Open AIDS J 2009;3:63-70. [PMID: 20148061 DOI: 10.2174/1874613600903010063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
171 Davies NE, Karstaedt AS. Antiretroviral outcomes in South African prisoners: a retrospective cohort analysis. PLoS One 2012;7:e33309. [PMID: 22470448 DOI: 10.1371/journal.pone.0033309] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
172 Chang CA, Meloni ST, Eisen G, Chaplin B, Akande P, Okonkwo P, Rawizza HE, Tchetgen Tchetgen E, Kanki PJ. Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria. Open Forum Infect Dis 2015;2:ofv154. [PMID: 26613097 DOI: 10.1093/ofid/ofv154] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
173 Shepherd BE, Jenkins CA, Parrish DD, Glass TR, Cescon A, Masabeu A, Chene G, de Wolf F, Crane HM, Jarrin I, Gill J, del Amo J, Abgrall S, Khaykin P, Lehmann C, Ingle SM, May MT, Sterne JA, Sterling TR; Antiretroviral Therapy Cohort Collaboration (ART-CC). Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis. AIDS 2013;27:1321-9. [PMID: 23925379 DOI: 10.1097/QAD.0b013e32835faa95] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
174 Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2012;26:2121-33. [PMID: 22695302 DOI: 10.1097/QAD.0b013e3283565dd1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
175 Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, Bohjanen PR, Sungkanuparph S, Easterbrook PJ, French MA, Boulware DR; International Network for the Study of HIV-associated IRIS (INSHI). Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis 2010;10:791-802. [PMID: 21029993 DOI: 10.1016/S1473-3099(10)70170-5] [Cited by in Crossref: 193] [Cited by in F6Publishing: 120] [Article Influence: 17.5] [Reference Citation Analysis]
176 Mandalakas AM, Kirchner HL, Walzl G, Gie RP, Schaaf HS, Cotton MF, Grewal HM, Hesseling AC. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting. Am J Respir Crit Care Med 2015;191:820-30. [PMID: 25622087 DOI: 10.1164/rccm.201406-1165OC] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
177 Tornheim JA, Dooley KE. Tuberculosis Associated with HIV Infection. Microbiol Spectr 2017;5. [PMID: 28233512 DOI: 10.1128/microbiolspec.TNMI7-0028-2016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
178 Hermans SM, van Leth F, Kiragga AN, Hoepelman AI, Lange JM, Manabe YC. Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery. Trop Med Int Health 2012;17:1527-33. [PMID: 23130871 DOI: 10.1111/tmi.12001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
179 Bruchfeld J, Correia-Neves M, Källenius G. Tuberculosis and HIV Coinfection. Cold Spring Harb Perspect Med 2015;5:a017871. [PMID: 25722472 DOI: 10.1101/cshperspect.a017871] [Cited by in Crossref: 72] [Cited by in F6Publishing: 48] [Article Influence: 12.0] [Reference Citation Analysis]
180 Masur H, Brooks JT, Benson CA, Holmes KK, Pau AK, Kaplan JE; National Institutes of Health., Centers for Disease Control and Prevention., HIV Medicine Association of the Infectious Diseases Society of America. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2014;58:1308-11. [PMID: 24585567 DOI: 10.1093/cid/ciu094] [Cited by in Crossref: 143] [Cited by in F6Publishing: 103] [Article Influence: 20.4] [Reference Citation Analysis]
181 Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009;23:1717-25. [PMID: 19461502 DOI: 10.1097/QAD.0b013e32832d3b6d] [Cited by in Crossref: 208] [Cited by in F6Publishing: 137] [Article Influence: 17.3] [Reference Citation Analysis]
182 Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood Pulmonary Tuberculosis: Old Wisdom and New Challenges. Am J Respir Crit Care Med 2006;173:1078-90. [DOI: 10.1164/rccm.200511-1809so] [Cited by in Crossref: 206] [Cited by in F6Publishing: 73] [Article Influence: 13.7] [Reference Citation Analysis]
183 Maokola WM, Ngowi BJ, Mahande MJ, Todd J, Robert M, Msuya SE. Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania. PLoS One 2021;16:e0254082. [PMID: 34255776 DOI: 10.1371/journal.pone.0254082] [Reference Citation Analysis]
184 Wood R, Lawn SD. Antiretroviral treatment as prevention: impact of the 'test and treat' strategy on the tuberculosis epidemic. Curr HIV Res 2011;9:383-92. [PMID: 21999773 DOI: 10.2174/157016211798038524] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
185 DeRiemer K, Kawamura LM, Hopewell PC, Daley CL. Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics. Am J Respir Crit Care Med 2007;176:936-44. [PMID: 17690336 DOI: 10.1164/rccm.200603-440OC] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
186 Mupfumi L, Moyo S, Shin SS, Wang Q, Zetola N, Molebatsi K, Nnawa J, Kgwaadira BT, Bewlay L, Chebani T, Iketleng T, Mogashoa T, Makhema J, Musonda RM, Essex M, Kasvosve I, Gaseitsiwe S. High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015. AIDS 2019;33:2415-22. [PMID: 31764106 DOI: 10.1097/QAD.0000000000002363] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
187 Majigo M, Somi G, Joachim A, Manyahi J, Nondi J, Sambu V, Rwebembera A, Makyao N, Ramadhani A, Maokola W, Todd J, Matee MI. Prevalence and incidence rate of tuberculosis among HIV-infected patients enrolled in HIV care, treatment, and support program in mainland Tanzania. Trop Med Health 2020;48:76. [PMID: 33579394 DOI: 10.1186/s41182-020-00264-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
188 Middelkoop K, Bekker LG, Myer L, Johnson LF, Kloos M, Morrow C, Wood R. Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Syndr 2011;56:263-9. [PMID: 21317585 DOI: 10.1097/QAI.0b013e31820413b3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
189 Shenoi SV, Brooks RP, Barbour R, Altice FL, Zelterman D, Moll AP, Master I, van der Merwe TL, Friedland GH. Survival from XDR-TB is associated with modifiable clinical characteristics in rural South Africa. PLoS One 2012;7:e31786. [PMID: 22412840 DOI: 10.1371/journal.pone.0031786] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
190 Bjerrum S, Bonsu F, Hanson-Nortey NN, Kenu E, Johansen IS, Andersen AB, Bjerrum L, Jarbøl D, Munck A. Tuberculosis screening in patients with HIV: use of audit and feedback to improve quality of care in Ghana. Glob Health Action 2016;9:32390. [PMID: 27569593 DOI: 10.3402/gha.v9.32390] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
191 Wolday D, Kebede Y, Legesse D, Siraj DS, McBride JA, Kirsch MJ, Striker R. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade. PLoS One 2020;15:e0233049. [PMID: 32442166 DOI: 10.1371/journal.pone.0233049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
192 Yamashita Y, Oe T, Kawakami K, Osada-Oka M, Ozeki Y, Terahara K, Yasuda I, Edwards T, Tanaka T, Tsunetsugu-Yokota Y, Matsumoto S, Ariyoshi K. CD4+ T Responses Other Than Th1 Type Are Preferentially Induced by Latency-Associated Antigens in the State of Latent Mycobacterium tuberculosis Infection. Front Immunol 2019;10:2807. [PMID: 31849981 DOI: 10.3389/fimmu.2019.02807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
193 Severe P, Juste MA, Ambroise A, Eliacin L, Marchand C, Apollon S, Edwards A, Bang H, Nicotera J, Godfrey C, Gulick RM, Johnson WD Jr, Pape JW, Fitzgerald DW. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med 2010;363:257-65. [PMID: 20647201 DOI: 10.1056/NEJMoa0910370] [Cited by in Crossref: 256] [Cited by in F6Publishing: 148] [Article Influence: 23.3] [Reference Citation Analysis]
194 Lewden C, Drabo YJ, Zannou DM, Maiga MY, Minta DK, Sow PS, Akakpo J, Dabis F, Eholié SP; IeDEA West Africa Collaboration. Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era. J Int AIDS Soc 2014;17:18797. [PMID: 24713375 DOI: 10.7448/IAS.17.1.18797] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
195 Du Bruyn E, Wilkinson RJ. The Immune Interaction between HIV-1 Infection and Mycobacterium tuberculosis. Microbiol Spectr 2016;4. [PMID: 28084192 DOI: 10.1128/microbiolspec.TBTB2-0012-2016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
196 Nicholas S, Sabapathy K, Ferreyra C, Varaine F, Pujades-Rodríguez M; AIDS Working Group of Médecins Sans Frontières. Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs. J Acquir Immune Defic Syndr 2011;57:311-8. [PMID: 21423023 DOI: 10.1097/QAI.0b013e318218a713] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
197 Golub JE, Pronyk P, Mohapi L, Thsabangu N, Moshabela M, Struthers H, Gray GE, McIntyre JA, Chaisson RE, Martinson NA. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009;23:631-636. [PMID: 19525621 DOI: 10.1097/qad.0b013e328327964f] [Cited by in Crossref: 152] [Cited by in F6Publishing: 89] [Article Influence: 13.8] [Reference Citation Analysis]
198 Naranbhai V, Hill AV, Abdool Karim SS, Naidoo K, Abdool Karim Q, Warimwe GM, McShane H, Fletcher H. Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy. J Infect Dis 2014;209:500-9. [PMID: 24041796 DOI: 10.1093/infdis/jit494] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 8.6] [Reference Citation Analysis]
199 Turinawe K, Vandebriel G, Lowrance DW, Uwinkindi F, Mutwa P, Boer KR, Mutembayire G, Tugizimana D, Nsanzimana S, Pevzner E, Howard AA, Gasana M. Operating Characteristics of a Tuberculosis Screening Tool for People Living with HIV in Out-Patient HIV Care and Treatment Services, Rwanda. PLoS One 2016;11:e0163462. [PMID: 27685783 DOI: 10.1371/journal.pone.0163462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
200 Saito S, Mpofu P, Carter EJ, Diero L, Wools-Kaloustian KK, Yiannoutsos CT, Beverly MS, Tsiouris S, Somi GR, Ssali J, Nash D, Elul B. Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012. J Acquir Immune Defic Syndr 2016;71:e96-e106. [PMID: 26910387 DOI: 10.1097/QAI.0000000000000896] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
201 Jerene D, Abebe W, Taye K, Suarez PG, Feleke Y, Hallström I, Ruff AJ. Tuberculosis along the continuum of HIV care in a cohort of adolescents living with HIV in Ethiopia. Int J Tuberc Lung Dis 2017;21:32-7. [PMID: 28157462 DOI: 10.5588/ijtld.16.0105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
202 Pollock KM, Montamat-Sicotte DJ, Grass L, Cooke GS, Kapembwa MS, Kon OM, Sampson RD, Taylor GP, Lalvani A. PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection. PLoS One 2016;11:e0146905. [PMID: 26756579 DOI: 10.1371/journal.pone.0146905] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
203 Gingo MR, Morris A. Pathogenesis of HIV and the lung. Curr HIV/AIDS Rep 2013;10:42-50. [PMID: 23079728 DOI: 10.1007/s11904-012-0140-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
204 Lawn SD, Harries AD, Williams BG, Chaisson RE, Losina E, De Cock KM, Wood R. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis 2011;15:571-81. [PMID: 21756508 DOI: 10.5588/ijtld.10.0483] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 7.2] [Reference Citation Analysis]